ALFA Filings
Every announcement, straight from the exchange
Every Titan Biotech other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Titan Biotech Limited has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Titan Biotech has dispatched letters to shareholders with unregistered emails, providing web links to access the FY 2025-26 Annual Report and 34th AGM Notice.
Titan Biotech Limited has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report, issued by practicing company secretary Mr. Amit Anand, confirms the company's compliance with SEBI regulations and secretarial standards.
Titan Biotech Ltd submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The Registrar and Share Transfer Agent, Beetal Financial, confirmed that security certificates received for dematerialization were processed, cancelled, and substituted in the register of members within the mandated 15-day timeline.